Pfizer Limited (BOM:500680)
4,523.90
+16.45 (0.36%)
At close: Jun 2, 2026
Pfizer Stock Forecast
Stock Price Forecast
According to 4 analysts polled by S&P Global, Pfizer stock has a consensus rating of "Strong Buy" and an average price target of ₹6,246. The average 1-year stock price forecast is 38.07% higher than the current stock price, while the lowest is ₹5,734 (+26.75%) and the highest is ₹7,500 (+65.79%).
Price Target: ₹6,246 (+38.07%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Pfizer stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Oct '25 | Nov '25 | Jan '26 | Feb '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 3 | 4 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 1 | 1 | 1 | 1 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 3 | 3 | 3 | 4 |
Financial Forecast
Revenue This Year
27.60B
from 25.20B
Increased by 9.53%
Revenue Next Year
30.18B
from 27.60B
Increased by 9.37%
EPS This Year
181.77
from 157.92
Increased by 15.10%
EPS Next Year
203.07
from 181.77
Increased by 11.72%
Financial currency is INR.
Revenue Forecast
| Revenue | 2027 | 2028 |
|---|---|---|
| High | 27.7B | |
| Avg | 27.6B | |
| Low | 27.5B |
Revenue Growth
| Revenue Growth | 2027 | 2028 |
|---|---|---|
| High | 10.0% | |
| Avg | 9.5% | |
| Low | 9.2% |
EPS Forecast
| EPS | 2027 | 2028 |
|---|---|---|
| High | 192.20 | |
| Avg | 181.77 | |
| Low | 173.50 |
EPS Growth
| EPS Growth | 2027 | 2028 |
|---|---|---|
| High | 21.7% | |
| Avg | 15.1% | |
| Low | 9.9% |
Sources: Price targets and consensus ratings provided by S&P Global Market Intelligence. Historical ratings and analyst data provided by TipRanks. Financial forecast data provided by S&P Global Market Intelligence. The data is sourced from Wall Street analysts. Data sources.